Tops & Flops Stocks
| Security | Change (%) ▲ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Oramed Pharmaceuticals | 7.160% | 2.244% | -9.591% | -13.489% | 3.355% | -76.331% | -32.749% |
| Premier Inc. | 7.240% | - | - | - | - | - | - |
| Hansa Medical AB | 7.330% | 15.206% | -3.376% | -44.816% | 5.057% | -82.647% | - |
| Grindeks AS | 7.330% | - | - | - | - | - | - |
| Infinity Pharmaceuticals Inc. | 7.360% | - | - | - | - | - | - |
| Grifols S.A. | 7.560% | 7.075% | -3.410% | -7.397% | -43.091% | -61.591% | -63.704% |
| Twist Bioscience Corp | 7.660% | 29.861% | 27.227% | 226.536% | 10.799% | -58.193% | - |
| Asensus Surgical Inc. | 7.720% | -3.510% | -8.299% | -60.800% | -26.340% | -86.607% | - |
| Trevena Inc. | 7.760% | 0.568% | 5.357% | -36.101% | -42.062% | -98.991% | -98.864% |
| Kineta Inc. | 7.920% | -2.679% | 7.921% | -85.923% | -82.862% | -99.406% | - |
| Pihlajalinna Oyj | 7.920% | 10.660% | 12.661% | -4.176% | 23.864% | -24.437% | -21.864% |
| Cellmid Ltd | 7.940% | - | - | - | - | - | - |
| Accuray Inc. | 7.950% | -29.412% | -35.135% | -54.717% | -45.455% | -61.290% | - |
| Compugen Ltd. | 7.980% | 12.011% | -10.889% | 248.696% | 23.006% | - | - |
| Korian S.A. | 8.050% | 27.253% | 37.680% | -68.993% | -2.692% | -92.640% | -93.313% |
| Poxel S.A. | 8.110% | -5.063% | -8.953% | -5.660% | 11.111% | -90.812% | -91.608% |
| Rewalk Robotics Ltd. | 8.120% | - | - | - | - | - | - |
| Corvus Pharmaceuticals Inc | 8.320% | 17.976% | 3.995% | 50.192% | 2.763% | -38.504% | -57.658% |
| Arch Therapeutics Inc | 8.430% | - | - | - | - | - | - |
| Akero Therapeutics Inc | 8.680% | -6.457% | -14.776% | -55.476% | -16.261% | - | - |
| Osmotica Pharmaceuticals PLC | 8.780% | - | - | - | - | - | - |
| Vita 34 AG | 8.790% | -1.240% | 6.222% | -33.053% | -8.779% | -71.463% | -67.034% |
| Verastem Inc. | 8.820% | 18.605% | -3.774% | 109.773% | 35.099% | -65.475% | - |
| Seres Therapeutics Inc | 9.070% | 37.510% | 52.015% | -80.306% | -18.817% | -93.707% | - |
| Alimera Sciences | 9.190% | - | - | - | - | - | - |